Stoddard Gregory J, Archer Melissa, Shane-McWhorter Laura, Bray Bruce E, Redd Doug F, Proulx Joshua, Zeng-Treitler Qing
Department of Internal Medicine, University of Utah.
College of Pharmacy, University of Utah.
AMIA Annu Symp Proc. 2015 Nov 5;2015:1174-83. eCollection 2015.
Ginkgo biloba is a widely used herbal product that could potentially have a severe interaction with warfarin, which is the most frequently prescribed anticoagulant agent in North America. Literature, however, provides conflicting evidence on the presence and severity of the interaction. In this study, we developed text processing methods to extract the ginkgo usage and combined it with prescription data on warfarin from a very large clinical data respository. Our statistical analysis suggests that taking concurrently with warfarin, gingko does significantly increase patients' risk of a bleeding adverse event (hazard ratio = 1.38, 95%CI: 1.20 to 1.58, p<.001). This study also is the first attempt of using a large medical record databaseto confirm a suspected herb-drug interaction.
银杏是一种广泛使用的草药产品,它可能与华法林发生严重相互作用,而华法林是北美最常用的抗凝血剂。然而,文献对于这种相互作用的存在及严重程度提供了相互矛盾的证据。在本研究中,我们开发了文本处理方法来提取银杏的使用情况,并将其与来自一个非常大的临床数据库的华法林处方数据相结合。我们的统计分析表明,与华法林同时服用时,银杏确实会显著增加患者发生出血不良事件的风险(风险比 = 1.38,95%置信区间:1.20至1.58,p <.001)。本研究也是首次尝试使用大型医疗记录数据库来证实一种疑似的草药-药物相互作用。